| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 4 |
| 1 | LAMIVUDINE ORAL | 4 |
| 2 | LOPINAVIR AND RITONAVIR | 4 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 3 |
| 5 | NELFINAVIR MESYLATE | 3 |
| 6 | ZIDOVUDINE | 3 |
| 7 | ABACAVIR | 2 |
| 8 | ABACAVIR SULFATE | 2 |
| 9 | DIAZEPAM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELFINAVIR MESYLATE | 3 | 0.0014 |
| 1 | LAMIVUDINE AND ZIDOVUDINE | 3 | 0.0004 |
| 2 | LOPINAVIR AND RITONAVIR | 4 | 0.0003 |
| 3 | ZIDOVUDINE | 3 | 0.0003 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 5 | NEVIRAPINE | 2 | 0.0002 |
| 6 | ABACAVIR SULFATE | 2 | 0.0002 |
| 7 | MISOPROSTOL | 2 | 0.0002 |
| 8 | EFAVIRENZ | 2 | 0.0002 |
| 9 | LAMIVUDINE | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 2 | Protease Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 4 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |